SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-015869
Filing Date
2021-08-05
Accepted
2021-08-05 16:18:35
Documents
63
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sgmo-20210630.htm   iXBRL 10-Q 1615205
7 EX-31.2 sgmo-20210630xex312.htm EX-31.2 10272
8 EX-32.1 sgmo-20210630xex321.htm EX-32.1 7218
9 EX-10.1 sgmo-20210631xex101_employ.htm EX-10.1 38219
10 EX-31.1 sgmo-20210631xex311.htm EX-31.1 10158
11 image_1a.jpg GRAPHIC 1190
  Complete submission text file 0001628280-21-015869.txt   7514255

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgmo-20210630.xsd EX-101.SCH 54406
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgmo-20210630_cal.xml EX-101.CAL 75378
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgmo-20210630_def.xml EX-101.DEF 208724
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sgmo-20210630_lab.xml EX-101.LAB 578823
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgmo-20210630_pre.xml EX-101.PRE 357266
12 EXTRACTED XBRL INSTANCE DOCUMENT sgmo-20210630_htm.xml XML 1389336
Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address 7000 MARINA BLVD BRISBANE CA 94005 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30171 | Film No.: 211148473
SIC: 2836 Biological Products, (No Diagnostic Substances)